KATELYN BONVOLANTA: Open Payments
NPI 1831609460 · MILFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 16 payments from 8 companies in 2025. Trend: 2023 $572 · 2024 $686 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $187 |
| Merck Sharp & Dohme LLC | 5 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $16 |
| BridgeBio Pharma, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, VERQUVO, JARDIANCE, CAMZYOS, SHINGRIX, LifeVest, Attruby, REPATHA.
Industry payments across MI — which companies pay providers there.
